Hepatitis B virus and hepatocellular carcinoma: antiviral therapy and risk estimation / 国际外科学杂志
International Journal of Surgery
;
(12): 846-848, 2012.
Article
in Chinese
| WPRIM
| ID: wpr-429822
ABSTRACT
The incidence of hepatocellular carcinoma is increasing year by year all over the world.Hepatoma has become one of the main causes of cancer-related death.For many years,studies found the chronic hepatitis B virus infection is the leading cause of hepatocellular carcinoma,and antiviral therapy for hepatitis B virus could obviously reduce the incidence of hepatoma and prevent recurrence after hepatectomy.Making appropriate risk estimation in patients with chronic hepatitis B and providing patients with high risk the effective medical intervention can help to prevent the occurrence and delay the development of hepatocellular carcinoma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Etiology study
Language:
Chinese
Journal:
International Journal of Surgery
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS